Previous work has shown that postnatal re-expression of WT Mecp2 copies in an RTT mouse model causes its phenotype to revert (Giacometti et al., 2007; Guy et al., 2007), which has sparked major interest in the RTT field in re-expressing WT MECP2 in human RTT patients. The gene discussed is MECP2; the disease is Rett syndrome.